DA32 Life Science Tech Acquisition Corp.

DALS

US23312M1062

DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 12, 2023 at 04:32 pm EDT

DA32 Life Science Tech Acquisition Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was USD 0.825611 million compared to net loss of USD 0.303364 million a year ago.

Latest news about DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) dropped from NASDAQ Composite Index	23-07-28	CI
DA32 Life Science Tech Acquisition to Redeem All Shares	23-07-21	MT
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
DA32 Life Science Tech Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-03-28	CI
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months Ended December 31, 2021	22-03-31	CI
Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022.	22-01-22	CI
DA32 Life Science Tech Acquisition Corp. Announces Executive Changes	21-07-30	CI
DA32 Life Science Tech Acquisition Corp. announced that it has received $6.5 million in funding from Da32 Sponsor Llc	21-07-29	CI
DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) added to NASDAQ Composite Index	21-07-29	CI
DA32 Life Science Tech Acquisition Corp. has completed an IPO in the amount of $200 million.	21-07-27	CI
DA32 Life Science Tech Acquisition Corp. has filed an IPO in the amount of $200 million.	21-07-02	CI
DA32 Life Science Tech Acquisition Corp. announced that it expects to receive $6.5 million in funding from Da32 Sponsor Llc	21-05-27	CI

Chart DA32 Life Science Tech Acquisition Corp.

Duration

Period

Chart DA32 Life Science Tech Acquisition Corp.

More charts

Company Profile

Da32 Life Science Tech Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search for business combination targets in separate areas of the life sciences industry, including life sciences tools, diagnostics, synthetic biology, and data and analytics platforms. The Company is not engaged in any business operations and has not generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M

Shell Companies